TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nova Bioenergi AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
4,827
|
4,394
|
1,642 |
| Financial expenses |
88
|
53
|
35 |
| Earnings before taxes |
141
|
320
|
131 |
| EBITDA |
496
|
569
|
334 |
| Total assets |
3,199
|
3,061
|
2,116 |
| Current assets |
1,613
|
1,592
|
976 |
| Current liabilities |
1,432
|
1,583
|
956 |
| Equity capital |
711
|
623
|
391 |
| - share capital |
26
|
26
|
29 |
| Employees (average) |
10
|
3
|
0 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
22.2%
|
20.4%
|
18.5% |
| Turnover per employee |
483
|
1,465 | |
| Profit as a percentage of turnover |
2.9%
|
7.3%
|
8.0% |
| Return on assets (ROA) |
7.2%
|
12.2%
|
7.8% |
| Current ratio |
112.6%
|
100.6%
|
102.1% |
| Return on equity (ROE) |
19.8%
|
51.4%
|
33.5% |
| Change turnover |
594
|
2,899
|
-176 |
| Change turnover % |
14%
|
194%
|
-10% |
| Chg. No. of employees |
7
|
3
|
0 |
| Chg. No. of employees % | 233% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.